**Core Concept**
Sideroblastic anemia is a group of disorders characterized by the accumulation of iron within mitochondria of red blood cell precursors, leading to ineffective erythropoiesis and anemia. This condition can be caused by genetic mutations, toxins, or other factors that disrupt normal mitochondrial function.

**Why the Correct Answer is Right**
Mercury is a heavy metal that primarily causes renal damage, neurological impairment, and immune system suppression. Unlike other options, mercury does not directly interfere with mitochondrial function or heme synthesis, which are key mechanisms leading to sideroblastic anemia. The correct answer is D, Mercury.

**Why Each Wrong Option is Incorrect**
**Option A:** INH (Isoniazid) is an antitubercular medication known to cause sideroblastic anemia by inhibiting the enzyme pyridoxine-dependent delta-aminolevulinic acid dehydratase (ALAD), essential for heme synthesis. This disrupts mitochondrial function and leads to iron accumulation.

**Option B:** L-DOPA is a precursor to dopamine used in the treatment of Parkinson's disease. It can cause sideroblastic anemia due to its ability to inhibit mitochondrial aconitase, an enzyme involved in the citric acid cycle, which is closely linked to heme synthesis.

**Option C:** Myelodysplastic anemia is a group of disorders characterized by ineffective erythropoiesis and impaired hematopoiesis. Sideroblastic anemia can be a feature of myelodysplastic syndromes due to genetic mutations affecting mitochondrial function or heme synthesis.

**Clinical Pearl / High-Yield Fact**
Keep in mind that sideroblastic anemia can be caused by a variety of factors, including genetic disorders, toxins, and medications. It's essential to identify the underlying cause to provide effective treatment and management.

**✓ Correct Answer: D. Mercury**